Corallino Diletta, Passera Roberto, Inama Marco
Hepatobiliary Surgery Division, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
Department of General Surgery and Surgical Specialties, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
Updates Surg. 2025 Mar 17. doi: 10.1007/s13304-025-02139-8.
Adrenalectomies are growing worldwide because of the frequent diagnosis of incidentaloma and the use of minimally invasive surgery (MIS). The factors used to identify a malignant lesion and the best surgical technique are uncertain. In this context, the definition of high-volume center and expert surgeon is under debate. The Italian Society of Endoscopic Surgery and New Technologies (SICE) developed a nationwide survey to investigate the state-of-the-art of adrenal surgery in Italy. A web-based survey comprising 37 questions was developed and distributed to Italian surgeons involved in adrenal surgery. Two hundred forty-eight answers were analyzed. Consensus was reached among the survey participants regarding local infiltration (83%) and rapid growth of the lesion (81%) as markers of malignancy. Nearly 30% of the participants used MIS in case of malignant adrenal lesions. The lateral (50%) and anterior transperitoneal (44%) approaches were the most common among Italian surgeons. Approximately 40% of participants believe that 20-40 adrenalectomies/year are needed to define an expert surgeon and at least 20 procedures/year to define a high-volume center. Approximately half of participants performed < 10 adrenalectomies/year in centers with a median volume < 10 procedures/year. Based on participant feedback, this survey highlights local infiltration and rapid growth as the most significant markers of malignant adrenal lesions. While open adrenalectomy remains the gold standard for suspected malignant lesions, nearly 30% of the participants practice MIS even in these cases. The lateral and anterior transperitoneal approaches emerge as the most familiar for Italian surgeons. A substantial proportion of Italian patients with adrenal lesions undergo surgery performed by surgeons with an annual case volume < 10 procedures, at centers with a low annual volume of adrenalectomies. Moreover, there is a lack of standardized definitions for 'expert surgeon' and 'high-volume center' in this context.
由于偶发瘤的频繁诊断以及微创外科手术(MIS)的应用,肾上腺切除术在全球范围内呈增长趋势。用于识别恶性病变的因素以及最佳手术技术尚不确定。在此背景下,高容量中心和专家外科医生的定义存在争议。意大利内镜外科学与新技术协会(SICE)开展了一项全国性调查,以研究意大利肾上腺手术的现状。他们设计了一项包含37个问题的网络调查,并分发给参与肾上腺手术的意大利外科医生。共分析了248份回复。调查参与者就局部浸润(83%)和病变快速生长(81%)作为恶性肿瘤标志物达成了共识。近30%的参与者在处理恶性肾上腺病变时采用了MIS。外侧入路(50%)和经腹前入路(44%)是意大利外科医生中最常用的方法。约40%的参与者认为,每年进行20 - 40例肾上腺切除术才能定义为专家外科医生,而定义一个高容量中心每年至少需要进行20例手术。在年手术量中位数小于10例的中心,约一半的参与者每年进行的肾上腺切除术少于10例。根据参与者的反馈,本次调查强调局部浸润和快速生长是恶性肾上腺病变最重要的标志物。虽然开放性肾上腺切除术仍是疑似恶性病变的金标准,但近30%的参与者即使在这些情况下也采用MIS。外侧和经腹前入路成为意大利外科医生最熟悉的方法。相当一部分患有肾上腺病变的意大利患者是由年手术量少于10例的外科医生在肾上腺切除术年手术量较低的中心进行手术的。此外,在这种情况下,对于“专家外科医生”和“高容量中心”缺乏标准化的定义。